Patient Characteristics | Response | Cases (%) | Controls (%) |
---|---|---|---|
Socio-Demographic Characteristics | |||
 Sex | Male | 75 (35) | 160 (38) |
Female | 137 (65) | 264 (62) | |
 Age category | 18–35 years | 118 (56) | 272 (64) |
36–55 years | 87 (41) | 136 (32) | |
> = 56 years | 7 (3) | 16 (4) | |
 Religion | Orthodox | 207 (98) | 409 (96) |
Other | 5 (2) | 15 (4) | |
 Marital status | Married | 96 (45) | 220 (52) |
Single | 25 (12) | 53 (12) | |
Divorced | 54 (25) | 100 (24) | |
Widowed | 37 (17) | 51 (12) | |
 Ethnicity | Amhara | 205 (97) | 416 (98) |
Others | 7 (3) | 8 (2) | |
 Residence | Rural | 39 (18) | 57 (13) |
Urban | 173 (82) | 367 (87) | |
 Educational status | Primary school & lower | 149 (70) | 283 (67) |
Secondary & higher | 63 (28) | 141(33) | |
 Had children | Yes | 137 (65) | 289 (68) |
Socio-Economic Characteristics | |||
 Has source of external support | Yes | 169 (80) | 385 (91) |
 Has disclosed HIV/AIDS status | Yes | 82 (39) | 257 (61) |
 Have public services | Yes | 150 (71) | 338 (80) |
 Owns a phone | Yes | 95 (45) | 256 (61) |
 Piped water | Yes | 104 (69) | 184 (54) |
 Own home | Yes | 147 (98) | 332 (98) |
 Electric light | Yes | 96 (64) | 262 (78) |
Clinical Characteristics | |||
 Baseline CD4 count | < 200 cells/ul | 142 (67) | 216 (51) |
200–350 cells/ul | 47 (22) | 131 (31) | |
> 350 cells/ul | 23 (11) | 77 (18) | |
 Current CD4 count | <  200 cells/ul | 24 (11) | 52 (12) |
200–350 cells/ul | 59 (28) | 79 (19) | |
>  350 cells/ul | 129 (61) | 293 (69) | |
 WHO clinical stage at baseline | Stage I | 33 (16) | 90 (21) |
Stage II | 26 (12) | 91 (21) | |
Stage III | 132 (62) | 215 (51) | |
Stage IV | 21 (10) | 28 (7) | |
 Current WHO clinical stage | Stage I | 209 (99) | 422 (98) |
> Stage I | 3 (1) | 2 (2) | |
 ART adherence | Good | 161 (76) | 394 (93) |
Fair | 28 (13) | 21 (5) | |
Poor | 23 (11) | 9 (2) | |
 Took therapeutic food | Yes | 59 (28) | 4 (0.94) |
 Had eating problems | Yes | 137 (65) | 112 (26) |
 Had opportunistic infection | Yes | 124 (58) | 143 (34) |
 Had anemia | Yes | 44 (21) | 48 (11) |
 Total duration of ART follow-up | <= 12 months | 7 (3) | 26 (6) |
>  12 months | 205 (97) | 398 (94) | |
 Follow-up interval | <= 3 months | 209 (99) | 420 (99) |
> = 3 months | 3 (1) | 4 (1) | |
 Pre-ART & ART follow up duration | <=12 months | 5 (2.4) | 18 (4) |
> 12 months | 207 (97.6) | 406 (96) |